In summary, despite the relatively small study group, our results show that some of the investigated SNVs within the IL2RA, CTAL4, and CD40 genes are more common in MS individuals, and others may have a protective role, indicating the need and importance of further investigation. The gene discussed is IL2RA; the disease is myeloid sarcoma.